+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report by Application (Drug Optimization & Repurposing, Preclinical Testing), by Therapeutic Area, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 80 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5595828
The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030. It is expected to expand at a CAGR of 29.4% from 2022 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.



The drug optimization and repurposing application segment held the largest revenue share in 2021. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2021. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2021. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights

  • The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 50.0% in 2021.
  • by therapeutic area, the oncology segment held the largest revenue share of over 20.0% in 2021. The infectious diseases segment is expected to register the fastest growth rate during the forecast period.
  • Asia Pacific is expected to expand at the fastest CAGR of 32.2% from 2022 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery.
  • North America led the market and accounted for a revenue share of over 55.0% in 2021. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Artificial Intelligence in Drug Discovery Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis
3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter’s Analysis
Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis
4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
4.2.1 Drug Optimisation and Repurposing Market Estimates and Forecasts, 2016-2030 (USD Million)
4.3 Preclinical Testing
4.3.1 Preclinical Testing Market Estimates and Forecasts, 2016-2030 (USD Million)
4.4 Other Applications
4.4.1 Other Applications Market Estimates and Forecasts, 2016-2030 (USD Million)
Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Oncology Market Estimates and Forecasts, 2016-2030 (USD Million)
5.3 Neurodegenerative Diseases
5.3.1 Neurodegenerative Diseases Market Estimates and Forecasts, 2016-2030 (USD Million)
5.4 Cardiovascular Disease
5.4.1 Cardiovascular Diseases Market Estimates and Forecasts, 2016-2030 (USD Million)
5.5 Metabolic Diseases
5.5.1 Metabolic Diseases Market Estimates and Forecasts, 2016-2030 (USD Million)
5.6 Infectious Disease
5.6.1 Infectious Diseases Market Estimates and Forecasts, 2016-2030 (USD Million)
5.7 Others
5.7.1 Others Market Estimates and Forecasts, 2016-2030 (USD Million)
Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis
6.1 Global Artificial Intelligence in Drug Discovery Market Movement Analysis, by region
6.2 Global Artificial Intelligence in Drug Discovery Market Share, by region, 2021 & 2030
6.3 North America
6.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.3.2 U.S.
6.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.3.3 Canada
6.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.4 Europe
6.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.4.2 U.K.
6.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.4.3 Germany
6.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.4.4 France
6.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.4.5 Spain
6.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.4.6 Italy
6.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.4.7 Russia
6.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.5 Asia Pacific
6.5.1 Asia Pacific AI in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.5.2 China
6.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.5.3 India
6.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.5.4 Japan
6.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.5.5 Australia
6.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.5.6 Singapore
6.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.5.7 South Korea
6.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.6 Latin America
6.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.6.2 Brazil
6.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.6.3 Mexico
6.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.6.4 Argentina
6.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.7 MEA
6.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.7.2 South Africa
6.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.7.3 Saudi Arabia
6.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
6.7.4 UAE
6.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates and Forecasts, 2016-2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3. Competitive Dashboard & Company Market Position Analysis
7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators
Chapter 8 Competitive Landscape
8.1 IBM Watson
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Offerings
8.1.4 Strategic Initiatives
8.2 Exscientia
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Offerings
8.2.4 Strategic Initiatives
8.3 GNS Healthcare
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Offerings
8.3.4 Strategic Initiatives
8.4 Alphabet (DeepMind)
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Offerings
8.4.4 Strategic Initiatives
8.5 Benevolent AI
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Offerings
8.5.4 Strategic Initiatives
8.6 BioSymetrics
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Offerings
8.6.4 Strategic Initiatives
8.7 Euretos.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Offerings
8.7.4 Strategic Initiatives
8.8 Berg Health
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Offerings
8.8.4 Strategic Initiatives
8.9 Atomwise
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Offerings
8.9.4 Strategic Initiatives
8.10 Insitro
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Offerings
8.10.4 Strategic Initiatives
8.11 Cyclica
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Offerings
8.11.4 Strategic Initiatives

Companies Mentioned

  • IBM Watson
  • Exscientia
  • Gns Healthcare
  • Alphabet (Deepmind)
  • Benevolent Ai
  • Biosymetrics
  • Euretos.
  • Berg Health
  • Atomwise
  • Insitro
  • Cyclica

Methodology

Loading
LOADING...